A synthetic peptide for use as a blocking control in assays to test for specificity of Gcom1 antibody, Alternative Names: GCOM1 control peptide, GCOM1 antibody Blocking Peptide, Anti-GCOM1 Blocking Peptide, FLJ30973 Blocking Peptide, GRINL1A Blocking Peptide, Gcom2 Blocking Peptide, Gup1 Blocking Peptide, Gup2 Blocking Peptide, MGC126694 Blocking Peptide, MGC138353 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
GCOM1
(GRINL1A Complex Locus (GCOM1))
Hintergrund
This gene (Gcom1) is part of a complex transcript unit that includes the gene for glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A (GRINL1A). Transcription of this gene occurs at an upstream promoter, with two different groups of alternatively spliced variants: Gup for GRINL1A upstream transcripts and Gcom for GRINL1A combined transcripts. The GRINL1A gene uses a downstream promoter for transcription and also has multiple alternatively spliced variants.